Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of CxBladder Monitoring for Recurrence of Urothelial Carcinoma in Low-, Intermediate-, and High-Risk Patients

NCT05080998 is registered in ClinicalTrials.gov with Pacific Edge Limited as lead sponsor.

NCT NCT05080998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05080998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of CxBladder Monitoring for Recurrence of Urothelial Carcinoma in Low-, Intermediate-, and High-Risk Patients
Lead sponsor
Pacific Edge Limited
Phase
Observational
Overall status
Active, not recruiting
Start date
June 8, 2022
Completion date
January 31, 2028
Enrollment
450 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial bladder cancer